Report
Should GLP-1 drugs be used to treat obesity in children?
New Scientist reports off-label prescriptions for children as young as 8, alongside concerns about long-term effects.
TLDR
New Scientist reports that a study found 9.3% of US children ages 8 to 11 with obesity but without diabetes are being prescribed GLP-1 drugs, up from 0.03% in 2019. It says there are signs the drugs treat obesity, but concerns remain about their long-term effects.
Combined views
10.2K
1 Source, first seen ago
3 likes3 comments1 saves1 reposts
